The effectiveness of a comprehensive lifestyle modification programme for asthma patients (ETHICO study): a randomized controlled trial

Not Applicable

• Conditions: J45; Asthma

• Registration Number: DRKS00003535
• Lead Sponsor: Faculty of Pharmacy in Hradec KraloveCharles University in Prague

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2010-03-15
• Study Start: 2012-02-10
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 27

Inclusion Criteria

All patients fulfilled the following inclusion criteria: 1. Patients had to be of age 18 and older, and 2. had an established diagnosis of mild-to-severe asthma for at least 6 months partially controlled or uncontrolled by symptomatic treatment based on GINA guidelines.

Exclusion Criteria

Exclusion criteria were: occupational asthma, oral or systematic corticosteroid use during the last 6 months, concomitant lung disease or a chronic unstable condition, use of any complementary therapies, use of specific allergen immunotherapy, current or past participation in an integrative self-management programme, current nicotine use, and pregnancy.

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
1. Asthma quality of life (AQLQ): <br>A higher score indicated better quality of life with a minimal important difference of 0.5=MID being considered a clinically significant change in asthma quality of life. <br><br>2. Asthma control (ACQ, ACT): <br>ACQ - A well-controlled asthma = a mean score of 0.75=ACQ. Uncontrolled asthma= a mean score of ACQ=1.5. <br>ACT - Well-controlled = a total score of 20=. Poorly controlled asthma = a total score of =15. <br><br>Outcomes (No. 1-2 ) are measured at baseline, at the end of the eight-week programme and a 4-month follow-up. <br>